Making history: Lab-grown cardiomyocytes successfully transplanted for 1st time

Lab-growing cardiomyocytes have been transplanted into a human patient for the first time in medical history, according to a report from the Japan Times.

The January operation, overseen by cardiovascular surgeon and Osaka University professor Yoshiki Sawa, was part of a clinical trial that’s looking to enroll 10 patients over the next three years. The first transplant was a success, and the Japan Times reported that patient is now recovering in the general ward at Osaka University Hospital.

Lab-grown heart muscle cells are transferred to a patient via “cell sheets,” Sawa explained, which are degradable sheets that attach to the surface of a patient’s heart. The induced pluripotent stem cells attached to the sheets are then expected to grow within the body and secrete a protein that regenerates blood vessels and improves cardiac function. Each sheet is around 4 to 5 centimeters wide and 0.1 millimeter thick.

“I hope that [the transplant] will become a medical technology that will save as many people as possible, as I’ve seen many lives that I couldn’t save,” Sawa said at a news conference.

Read the full story below:

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."